» Articles » PMID: 23844572

CD36 Gene Variants and Their Association with Type 2 Diabetes in an Indian Population

Overview
Date 2013 Jul 13
PMID 23844572
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type 2 diabetes mellitus (T2DM) is a multifactorial disease resulting from ineffective use of insulin in the body. Single nucleotide polymorphisms (SNPs) in genes for scavenger receptors such as CD36 have been implicated in the pathogenesis of atherosclerosis and cardiovascular diseases in diabetes. The present study evaluated the effect of genetic polymorphisms of the CD36 gene on the risk of developing T2DM. Four SNPs in the CD36 gene (-178A→C in the promoter region, rs1984112 [A→G in exon 1A], rs1527479 [T→C in intron IB], and rs3211938 [T→G in exon 10]) were screened in T2DM patients and healthy controls (n=100 each).

Materials And Methods: Analysis of CD36 gene polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism. Statistical analysis was done by Fisher's exact test and χ² statistics using SPSS version 15.0 software (SPSS, Inc., Chicago, IL), whereas SHEsis software (available at http://analysis.bio-x.cn/myAnalysis.php ) was used for haplotype analysis.

Results: There was genotypic association of rs3211938 (T→G) polymorphism with T2DM (P=0.046), whereas rs1984112 (A→G) and rs1527479 (T→C) SNPs showed no association. The minor alleles of SNPs ("G" of rs1984112, "C" of rs1527479, and "G" of rs3211938) showed significant association with clinical profiles in T2DM patients (P<0.05). Analysis also showed that the "GCG" haplotype had a significant association with T2DM (P=0.026; odds ratio=3.12; 95% confidence interval 1.089-8.939). Significant association of the CD36 gene was confirmed by linkage disequilibrium patterns.

Conclusions: The CD36 variants may help to determine the T2DM susceptibility in the North Indian population. However, genotyping of variants in more individuals and studies in other populations will be required to validate the results and ethnic variations.

Citing Articles

Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus.

Wang X, Ma X, Xu J, Guo Y, Zhou S, Yu H Front Nutr. 2022; 9:981200.

PMID: 36185686 PMC: 9515475. DOI: 10.3389/fnut.2022.981200.


Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis.

Hatmal M, Alshaer W, Mahmoud I, Al-Hatamleh M, Al-Ameer H, Abuyaman O PLoS One. 2021; 16(10):e0257857.

PMID: 34648514 PMC: 8516279. DOI: 10.1371/journal.pone.0257857.


The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.

Moon J, Karunakaran U, Suma E, Chung S, Won K Diabetes Metab J. 2020; 44(2):222-233.

PMID: 32347024 PMC: 7188969. DOI: 10.4093/dmj.2020.0053.


Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice.

Ren Z, Yang Z, Lu Y, Zhang R, Yang H Mol Med Rep. 2020; 21(6):2475-2483.

PMID: 32236613 PMC: 7185284. DOI: 10.3892/mmr.2020.11041.


Pharmacogenetic studies update in type 2 diabetes mellitus.

Singh S, Usman K, Banerjee M World J Diabetes. 2016; 7(15):302-15.

PMID: 27555891 PMC: 4980637. DOI: 10.4239/wjd.v7.i15.302.